Effect of ractopamine on growth, carcass traits, and fasting heat production of U.S. contemporary crossbred and Chinese Meishan pure- and crossbred pigs.

Twenty-four U.S. crossbred (Duroc x White composite; D x Wc; 83.9 kg), 24 purebred Meishan (M; 59.4 kg), and 24 Meishan x White composite crossbred (M x Wc; 83.4 kg) barrows were allotted within genotype to a 16% CP corn-soybean meal diet or this basal diet + 20 ppm of ractopamine and allowed ad libitum access to feed for 52 d. No genotype x ractopamine interactions were detected (P greater than .05) in pigs for growth, lean cuts, ham and loin characteristics, leaf fat and visceral organ weights, fasting whole-animal heat production, and carcass traits except longissimus muscle area (LMA). The LMA was increased by ractopamine in D x Wc and M x Wc pigs (P less than .05) but not in M pigs. Compared with D x Wc and M x Wc pigs, M pigs had lower ADG, ADFI, and gain to feed ratio (G/F), shorter carcasses, and lower dressing percentage, LMA, predicted amount of muscle, weights of trimmed picnic, loin, and ham cuts, percentage of ham lean, and CP in ham lean, but heavier liver, kidneys, pancreas, and entire gastrointestinal tract with greater percentage of ham fat and ham bone (P less than .05). The M x Wc pigs had lower ADG, G/F, dressing percentage, LMA, amount of muscle, weights of trimmed cuts, and percentage of ham lean but heavier lungs, pancreas, stomach, and large intestine than did D x Wc pigs (P less than .05). Supplemental ractopamine increased ADG, G/F, dressing percentage, amount of muscle, trimmed loin weight, percentage of ham lean, and CP in ham lean and decreased weights of heart, lungs, kidneys, and pancreas in pigs (P less than .05). Neither genotype nor ractopamine had any effect on 4- to 24-h postprandial whole-animal heat production of pigs (P greater than .05). These results indicate that ractopamine will improve growth performance and carcass leanness in pure- and crossbred Meishan pigs.     

Differences among breed crosses of cattle in the conversion of food energy to calf weight during the preweaning interval

The objective of this study was to determine whether F1 cows that differ in genetic potential for weight at maturity and milk yield vary in the conversion of food energy to calf weight gain. Food intakes and weight change data were recorded by pen for cows and calves from approximately 45 d postpartum. Cows assigned to the study were 7- to 9-yr-old F1s produced by top-crossing Angus, Hereford, Brown Swiss, Chianina, Gelbvieh; Maine Anjou, and Red Poll sires to either Angus or Hereford dams. Calves were sired by Simmentals. Experimental units were pens (10 to 12 cow/calf pairs); pen was replicated within breed of sire in each of 2 yr (n = 24). Calf weight gain and energy consumed by the dams differed among the F1s, as did the ratio of calf weight gain to energy consumed by the calf and cow. Angus or Hereford (35.8), Red Poll (35.7), or Maine Anjou (35.6) F1s produced more calf weight per unit of energy consumed (g/Mcal) by the cow and calf than Chianina (33.1) or Gelbvieh (33.7) F1 females; Brown Swiss cows were intermediate (34.3). Differences in food conversion efficiency exist among breed crosses. These differences seem to be associated with breed cross differences in genetic potential for milk yield and mature weight; an exception to this trend was the Maine Anjou.     

Technical note: a double L intestinal cannula for cattle

A double L-shaped intestinal cannula was developed in an attempt to overcome problems observed previously with simple T-type cannulas. The cannula was constructed from cyclopolyvinyl chloride water pipe fittings. Construction materials were fairly rigid, but by connecting the split cannula pieces with elastic castration bands the cannula had some flexibility. Placing a short cone over the exposed cannula barrel reduced mechanical damage to the intestine. The double L cannula required a much smaller incision in the intestine during surgical insertion than a T-type cannula; it also simplified replacement. Construction is described; use and performance of the cannula has been satisfactory.     

Nutritional, physiological, genetic, sex, and age effects on fat-free dry matter composition of the body in avian, fish, and mammalian species: a review

The purpose of this review is to outline and interpret the effects of nutrition, physiological state, sex, genetics, and age on composition of the fat-free dry matter of birds, mammals, and fishes in order to test the hypothesis that the protein:ash ratio in the body is constant. Calculations from a broad array of published data revealed that nutritional factors, including mineral, protein and amino acid nutriture, frequency and level of feeding, and energy intake and nonnutritional factors, including physiological state, sex, genetic background, and age of animal, may each alter the ratio of protein:ash in the body. All or part of the response may be associated with changes in accretion of body protein and(or) skeletal development and mineralization imposed by these nutritional and nonnutritional factors. In most cases of amino acid or protein deficiency, the protein:ash ratio was decreased relative to the control because the deposition of protein in muscle and viscera was reduced more than the growth and mineralization of the skeleton. In other cases, the protein:ash ratio was increased relative to a control because the dietary Ca or P intake or absorption limited skeletal mineralization. More knowledge is needed of how skeletal development and protein:ash ratio in the body is regulated, especially under the influence of nutritional, ontogenetic, and physiological variables among different genotypes of mammals, birds, and fishes. Documentation that the protein:ash ratio in the whole body of representative mammals, birds, and fishes is not constant, but is subject to manipulation, has important physiological and economic implications for developing food animals for the efficient production of lean meat.     

Comparison of three methods of feeding colostrum to dairy calves

Absorption of colostral immunoglobulins by Holstein calves was studied in 3 herds in which 3 methods of colostrum feeding were used. Failure of passive transfer, as determined by calf serum immunoglobulin G1 (IgG1) concentration less than 10 mg/ml at 48 hours of age, was diagnosed in 61.4% of calves from a dairy in which calves were nursed by their dams, 19.3% of calves from a dairy using nipple-bottle feeding, and 10.8% of calves from a dairy using tube feeding. The management factor determined to have the greatest influence on the probability of failure of passive transfer in the herds using artificial methods of colostrum feeding (bottle feeding or tube feeding) was the volume of colostrum fed as it affected the amount of IgG1 received by the calf. In dairies that used artificial feeding methods, failure of passive transfer was infrequent in calves fed greater than or equal to 100 g IgG1 in the first colostrum feeding. In the dairy that allowed calves to suckle, prevalence of failure of passive transfer was greater than 50% even among calves nursed by cows with above-average colostral IgG1 concentration. Analysis of the effect of other management factors on calf immunoglobulin absorption revealed small negative effects associated with the use of previously frozen colostrum and the use of colostrum from cows with long nonlactating intervals.     

Efficacy of parenteral antibiotics for disease prophylaxis in feedlot calves

Trimethoprim-sulfadoxine (TMPSDX) and two formulations of oxytetracycline (OTC) were examined for their prophylactic efficacy in feedlot calves when given by intramuscular injection on arrival at a large commercial feedlot. The study included 2,112 high-risk feeder calves that developed disease early in the feeding period. Both formulations of OTC reduced bovine respiratory disease morbidity during the first two weeks on feed and for the entire feeding period by 15-19% (p<0.05), and they also reduced all fatal fibrinous pneumonia by 67% and 84% (p<0.05). All three drugs significantly reduced all fatal disease in animals first treated during the second week on feed, but not for the overall feeding period. Oxytetracycline with 2-pyrrolidone reduced the incidence of all fatal disease by 44% (p<0.05) during the entire feeding period. The case fatality risk for calves first treated during the second week on feed was lower (p<0.05) in the TMPSDX group and in the OTC with polyvinyl-pyrrolidone group.     

Influence of Disease Process and Duration on Acute Phase Proteins in Serum and Peritoneal Fluid of Horses with Colic

Background

The acute phase proteins (APP) serum amyloid A (SAA), haptoglobin, and fibrinogen are valuable blood biomarkers in equine inflammatory diseases, but knowledge of factors influencing their concentrations in blood and peritoneal fluid (PF) of horses with colic is needed.

Objectives

The objective of this study was to investigate the influence of demographics (age, sex, breed), disease process (simple obstruction, strangulating obstruction, inflammatory), disease location, disease duration, hypovolemia, and admission hospital on concentrations of APP, lactate and white blood cell counts (WBC) in horses with colic admitted to 2 referral hospitals.

Animals

The study included 367 horses with colic admitted at 2 referral hospitals.

Methods

Prospective multicenter observational study of clinical data, as well as blood and PF biomarkers. Associations between biomarker concentrations and clinical variables were analyzed using multivariate linear regression analysis.

Results

Increasing pre‐admission duration of colic was associated with increased concentrations of APP in blood and PF. Blood concentrations of SAA and fibrinogen were associated with disease process (inflammatory, strangulations, simple obstructions) in more colic duration groups (5–12 and >24 hours) than any of the other biomarkers. No relevant associations between demographic factors, hospital, or hydration status and the measured biomarkers were found.

Conclusions and Clinical Importance

In horses with colic, concentrations of APP are associated mainly with disease process and duration of colic and may thus be used for assessment of disease independently of demographic or geographic factors. Serum amyloid A may be a diagnostic marker for use in colic differential diagnosis, but further evaluation is needed.     

Behavioral Abnormalities in Lagotto Romagnolo Dogs with a History of Benign Familial Juvenile Epilepsy: A Long‐Term Follow‐Up Study

Background

Lagotto Romagnolo (LR) dogs with benign juvenile epilepsy syndrome often experience spontaneous remission of seizures. The long‐term outcome in these dogs currently is unknown. In humans, behavioral and psychiatric comorbidities have been reported in pediatric and adult‐onset epilepsies.

Hypothesis/Objectives

The objectives of this study were to investigate possible neurobehavioral comorbidities in LR with a history of benign familial juvenile epilepsy (BFJE) and to assess the occurrence of seizures after the remission of seizures in puppyhood.

Animals

A total of 25 LR with a history of BFJE and 91 control dogs of the same breed.

Methods

Owners of the LR dogs in the BFJE and control groups completed an online questionnaire about each dog''s activity, impulsivity, and inattention. Principal component analysis (PCA) served to extract behavioral factors from the data. We then compared the scores of these factors between the 2 groups in a retrospective case–control study. We also interviewed all dog owners in the BFJE group by telephone to inquire specifically about possible seizures or other neurological problems after remission of seizures as a puppy.

Results

Lagotto Romagnolo dogs with BFJE showed significantly higher scores on the factors Inattention and Excitability/Impulsivity than did the control group (P = .003; P = .021, respectively). Only 1 of the 25 BFJE LR exhibited seizures after remission of epilepsy in puppyhood.

Conclusions and Clinical Importance

Although the long‐term seizure outcome in BFJE LR seems to be good, the dogs exhibit behavioral abnormalities resembling attention deficit hyperactivity disorder (ADHD) in humans, thus suggesting neurobehavioral comorbidities with epilepsy.     

Pharmacokinetics and pharmacodynamics of three formulations of firocoxib in healthy horses

The objectives of this study were to compare the pharmacokinetics and COX selectivity of three commercially available formulations of firocoxib in the horse. Six healthy adult horses were administered a single dose of 57 mg intravenous, oral paste or oral tablet firocoxib in a three‐way, randomized, crossover design. Blood was collected at predetermined times for PGE₂ and TXB₂ concentrations, as well as plasma drug concentrations. Similar to other reports, firocoxib exhibited a long elimination half‐life (31.07 ± 10.64 h), a large volume of distribution (1.81 ± 0.59L/kg), and a slow clearance (42.61 ± 11.28 mL/h/kg). Comparison of the oral formulations revealed a higher C_max, shorter T_max, and greater AUC for the paste compared to the tablet. Bioavailability was 112% and 88% for the paste and tablet, respectively. Maximum inhibition of PGE₂ was 83.76% for the I.V. formulation, 52.95% for the oral paste formulation, and 46.22% for the oral tablet formulation. Pharmacodynamic modeling suggests an IC₅₀ of approximately 27 ng/mL and an IC₈₀ of 108 ng/ mL for COX2 inhibition. Inhibition of TXB₂ production was not detected. This study indicates a lack of bioequivalence between the oral formulations of firocoxib when administered as a single dose to healthy horses.